Clinical Efficacy of Ivabradine Combined with Sodium Aescinate in the Treatment of Senile Heart Failure Complicated with Chronic Obstructive Pulmonary Disease
ZENG Xin-chun, LI Jin-ke
Department of Cardiovascular Medicine, Eastern Hospital, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Shaanxi 710089
Abstract：【Objective】 To investigate the clinical efficacy of ivabradine combined with sodium aescinate in elderly patients with heart failure complicated with chronic obstructive pulmonary disease (COPD). 【Methods】 A total of 92 elderly patients with heart failure complicated with COPD treated in the First Affiliated Hospital of Xi'an Jiaotong University from March 2019 to June 2020 were randomly divided into observation group (treated with ivabradine combined with sodium aescinate) and control group (treated with ivabradine), with 46 cases in each group. The cardiac function, pulmonary function and exercise endurance of the two groups were compared before and after treatment, and the adverse reactions of the two groups were recorded. 【Results】After treatment, the left ventricular ejection fraction, left ventricular end diastolic diameter, left ventricular end diastolic volume and ventricular septal diastolic thickness in the two groups were higher than those before treatment, and the difference between the observation group and the control group was statistically significant (P<0.05); The forced vital capacity, forced expiratory volume in the first second and 6-minute walking distance of the two groups were higher than those before treatment (P<0.05), and the observation group was higher than that of the control group (P<0.05). The incidence of adverse reactions in the observation group was 13.04% (6/46), higher than 8.70% (4/46) in the control group, but the difference was not statistically significant (χ2=0.45=0.45, P=0.50>0.05). 【Conclusion 】Ivabradine combined with sodium aescinate can significantly improve the heart and lung function and exercise endurance of elderly patients with heart failure and COPD, with good safety and certain clinical value.
曾新春, 李金科. 伊伐布雷定联合七叶皂苷钠治疗老年心力衰竭合并慢性阻塞性肺疾病的临床疗效[J]. 医学临床研究, 2022, 39(3): 390-392.
ZENG Xin-chun, LI Jin-ke. Clinical Efficacy of Ivabradine Combined with Sodium Aescinate in the Treatment of Senile Heart Failure Complicated with Chronic Obstructive Pulmonary Disease. JOURNAL OF CLINICAL RESEARCH, 2022, 39(3): 390-392.
[1] CANEPA M, FRANSSEN F M, OLSCHEWSKI H, et al. Diagnostic and therapeutic gaps in patients with heart failure and chronic obstructive pulmonary disease[J].JACC Heart Fail,2019, 7(10):823-833.
[2] 朱华, 史凯蕾, 朱菲白,等. 老年心力衰竭合并慢性阻塞性肺疾病患者应用琥珀酸美托洛尔缓释片2年随访[J].老年医学与保健, 2019, 25(1):35-39.
[3] IDE T, OHTANI K, HIGO T, et al. Ivabradine for the treatment of cardiovascular diseases[J].Circ J,2019, 83(2):252-260.
[4] HUANG X J, WANG D G, YE L C, et al. Sodium aescinate and its bioactive components induce degranulation via oxidative stress in RBL-2H3 mast cells[J].Toxicol Res,2020, 9(4):413-424.
[5] MALTAIS F, BUHL R, KOCH A, et al. β-blockers in COPD: A cohort study from the tonado research program[J].Chest,2018, 153(6):1315-1325.
[6] TSUTSUI H, MOMOMURA S I, YAMASHINA A, et al. Efficacy and sfety of ivabradine in Japanese patients with chronic heart failure-J-SHIFT study[J].Circ J,2019, 83(10):2049-2060.
[7] 陆瑶华,沈卫华. 伊伐布雷定联合左西孟旦对老年慢性心力衰竭患者心室重构的影响[J].中国医药导报,2020,17(27):123-126.
[8] LI L, XU B, LI C R, et al. Anti-proliferation and apoptosis-inducing effects of sodium aescinate on retinoblastoma Y79 cells[J].Int J Ophthalmol,2020, 13(10):1546-1553.
[9] 文雯, 陈艳, 凌天金, 等. β七叶皂苷钠注射液联合布美他尼注射液治疗急性脑梗死伴脑水肿的临床研究[J].中国临床药理学杂志, 2018, 34(7):744-746.
[10] 方泽波, 侯玉清, 谢晋国, 等. 注射用七叶皂苷钠联合盐酸尼卡地平注射液治疗高血压脑出血患者的临床研究[J].中国临床药理学杂志, 2018, 34(6):618-621.
[11] 王紫汀,赵芳,姜国荣,等. 热疗联合注射用七叶皂苷钠治疗类肺炎性胸腔积液的临床研究[J].中国医药导报,2019,16(18):113-116.
2022, Vol. 39 
